Banner - NPPA Connect
News|Articles|July 23, 2026

What to Expect at the Society for Pediatric Dermatology 2026 Annual Meeting

Listen
0:00 / 0:00

Key Takeaways

  • Minneapolis programming spans complex pediatric dermatology, practice management, diversity and inclusion, and multidisciplinary collaboration, pairing foundational education with rapid-cycle therapeutic updates and interactive case discussions.
  • Hurwitz and Founders lectures cover histiocytosis/dermatopathology, novel topical therapies and biologics, and a 30-year retrospective of pediatric dermatology’s evolution.
SHOW MORE

Pediatric dermatology experts will gather in Minneapolis for SPD's Annual Meeting: will you be there?

The 2026 Society for Pediatric Dermatology (SPD) Annual Meeting begins today, bringing pediatric dermatology specialists to Minneapolis, Minnesota, for a program spanning complex medical dermatology, practice management, diversity and inclusion, and emerging therapeutics. This year's agenda combines foundational educational sessions with interactive case discussions, updates on rapidly evolving treatment options, and opportunities for multidisciplinary collaboration.

Featured Disease States and Presentations:

  • Atopic dermatitis
  • Blistering
  • Café-Au-Lait macules
  • Dermatomyositis
  • Hemangiomas
  • Hidradenitis suppurativa
  • Histiocytosis and other cancers
  • Melanoma
  • Neonatal lupus
  • Rare diseases
  • Vitiligo

Some clinical highlights include the Hurwitz Lectures by Mark Koh, MD, on histiocytosis and dermatopathology, Amy Paller, MD, presenting new topical therapies and biologics, and Anthony Mancini, MD, reflecting on three decades of pediatric dermatology during the Founders Lecture. Attendees can also expect updates on immunosuppressive medication monitoring, financial updates for pediatric dermatologists, PeDRA research, and year-in-review sessions summarizing the latest advances across the specialty.

Interactive learning remains a hallmark of the meeting, with the return of Sam Weinberg's Cases of the Year, featuring challenging diagnostic cases ranging from metastatic infantile melanoma and neonatal lupus to pediatric hidradenitis suppurativa, rare genodermatoses, and complex inflammatory diseases. Master Class sessions led by Sarah Chamlin, MD; Nanette Silverberg, MD; and Jonathan Dyer, MD, will provide focused practical guidance on ulcerated infantile hemangiomas, widespread vitiligo, and café-au-lait macules.

The meeting also addresses important issues beyond clinical care. Sessions on caring for gender minority youth, social media's impact on body dysmorphic disorder, hair care for kinky and curly hair, and clinical efficiency reflect the increasingly diverse challenges facing pediatric dermatologists. Dedicated programming for advanced practice providers, residents, early-career physicians, and underrepresented in medicine (URiM) attendees will further emphasize professional development across career stages.

Dermatology Times will be on-site in Minneapolis covering the meeting’s latest updates from July 22 to 25th. To keep up with all the exciting interviews, posters, and news, be sure to subscribe here.

Will you be there? Let us know by answering the poll below, commenting on our social media, or emailing us at DTEditor@mmhgroup.com.

Will you be at this year's SPD Annual Meeting?

Yes, in person
Yes, virtually
No, not this year

Related to this article

Day 3 Recap: Fall Clinical 2026
Day 3 of Fall Clinical 2026 featured roflumilast data in genital psoriasis, long-term JAK inhibitor safety in atopic dermatitis, and expert insights on setting expectations in HS, treating advanced cSCC, and screening aesthetic patients.
Day 2 Recap: Fall Clinical 2026
The second day of Fall Clinical 2026 brought new psoriasis data on ixekizumab plus tirzepatide and 2-year icotrokinra results, along with 3-year nemolizumab findings, upadacitinib switch data, and expert guidance on choosing a biologic in atopic dermatitis.